← All trials
NCT07302945
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 4, 2022
- Primary completion
- Jan 14, 2022
- Completion date
- May 2, 2022
- First posted
- Dec 24, 2025
- Last posted
- Dec 26, 2025
- Enrollment
- 1
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Bionoxx Inc.Lead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.